Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Assess Safety and Efficacy of ELAD in Severe Acute Alcoholic Hepatitis Steroid Failures

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by Vital Therapies, Inc.
Sponsor:
Information provided by (Responsible Party):
Vital Therapies, Inc.
ClinicalTrials.gov Identifier:
NCT01829347
First received: April 8, 2013
Last updated: January 29, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)
No publications provided by Vital Therapies, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):